Search company, investor...

Insight Pharmaceuticals

Founded Year



Acquired | Acquired

Total Raised




About Insight Pharmaceuticals

Insight Pharmaceuticals is a consumer products company that is quietly transforming the over-the-counter (OTC) marketplace. Insight is a privately held company with an aggressive growth strategy built upon the acquisition of a recognizable set of OTC women's health and personal care products. Founded in 1996 with the express mission of acquiring underperforming niche consumer OTC products, Insight has increased targeted acquisitions over the past several years to build a formidable portfolio of solid brands.

Headquarters Location

900 Northbrook Drive Suite 200

Feasterville Trevose, Pennsylvania, 19053,

United States


Missing: Insight Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Insight Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Insight Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Insight Pharmaceuticals is included in 1 Expert Collection, including Women's Health & Wellness.


Women's Health & Wellness

1,484 items

Startups focused on providing products and services catering to women's health and wellbeing.

Insight Pharmaceuticals Patents

Insight Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Arthropod anatomy
  • Colloidal chemistry
  • Essential oils
patents chart

Application Date

Grant Date


Related Topics



Food additives, Essential oils, Colloidal chemistry, Arthropod anatomy, Medicinal plants


Application Date


Grant Date


Related Topics

Food additives, Essential oils, Colloidal chemistry, Arthropod anatomy, Medicinal plants



Latest Insight Pharmaceuticals News

Swander Pace Capital completes sale of Clarion Brands to Bridges Consumer Healthcare

Jan 22, 2021

Consumer HealthcareSubmitted22/01/2021 - 4:47pmSwander Pace Capital (SPC) has completed the sale of Clarion Brands, a consumer products company specialising in over-the-counter (OTC) healthcare solutions and dietary supplements, to Bridges Consumer Healthcare LLC, a consumer healthcare company partnering with Charlesbank Capital Partners.Clarion markets a portfolio of leading niche OTC and dietary supplements brands that are sold to food, drug, mass, and online retailers throughout the United States and Canada.Swander Pace Capital partnered with the former management team of Insight Pharmaceuticals following its sale to Prestige Brands Holdings in 2014, and created the Clarion consumer healthcare platform. Under the ownership of SPC, Clarion built its product portfolio of seven brands specializing in over-the-counter healthcare solutions, including three No1 healthcare professional (“HCP”) recommended brands: Florajen Probiotics, the No1 pharmacist recommended probiotic brand where carried, Lipo-Flavonoid, the No1 ENT doctor recommended OTC product for ringing in the ears (tinnitus) and Certain Dri, the No1 doctor recommended OTC brand for controlling excessive underarm sweating (hyperhidrosis).“The SPC team was essential in providing the guidance and financial support to grow our business, and it’s been our pleasure to work with them through two very successful transactions,” says Gary Downing, CEO of Clarion. “Our work together has helped accelerate our value creation initiatives, including new product innovation, growth with our retail partners, unique HCP outreach initiatives and aggressive efforts to build out e-commerce channels.”“We are very proud to have partnered with Gary and the Clarion team for another successful investment in the OTC category,” says Mo Stout, Managing Director at Swander Pace Capital. “Through significant brand development, innovation, and operational execution, we were able to create a best-in-class OTC platform company. We want to thank the entire Clarion team for all of their hard work during our ownership, and we look forward to watching the brands continue to grow and flourish as part of the Bridges organisation.”Sawaya Partners, LLC served as exclusive financial advisor to Clarion and Swander Pace Capital, and Kirkland & Ellis LLP acted as legal counsel to Clarion and Swander Pace Capital on the transaction.Author ProfileTagsDeals & TransactionsExits -

Insight Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Insight Pharmaceuticals founded?

    Insight Pharmaceuticals was founded in 2002.

  • Where is Insight Pharmaceuticals's headquarters?

    Insight Pharmaceuticals's headquarters is located at 900 Northbrook Drive, Feasterville Trevose.

  • What is Insight Pharmaceuticals's latest funding round?

    Insight Pharmaceuticals's latest funding round is Acquired.

  • How much did Insight Pharmaceuticals raise?

    Insight Pharmaceuticals raised a total of $80.6M.

  • Who are the investors of Insight Pharmaceuticals?

    Investors of Insight Pharmaceuticals include Prestige Brands Holdings, Ares Capital Corporation, Swander Pace Capital and Allied Capital.

  • Who are Insight Pharmaceuticals's competitors?

    Competitors of Insight Pharmaceuticals include Ology Bioservices, Kala Pharmaceuticals, Salix Pharmaceuticals, Peckforton Pharmaceuticals, ANI Pharmaceuticals and 10 more.

Compare Insight Pharmaceuticals to Competitors

Novast Pharmaceuticals

Novast is a generic and specialty pharmaceutical company, operated in both China and the United States. Novast is dedicated to upholding the highest quality and drug delivery technology in product development and commercial manufacturing. The company integrates science and technology with quality in all disciplines to develop and supply cost-effective and affordable products with global strategic alliances for the worldwide regulated markets.

Union Springs

Union Springs Pharmaceuticals founded in 2007 and based in Union, Kentucky is a subsidiary of Xanodyne Pharmacal. Union Springs Pharmaceuticals is engaged in the licensing, acquisition, development and commercialization of over-the-counter drug and device products.

Pondera Pharmaceuticals

Pondera Pharmaceutical is a stealth mode pharmaceuticals company.

Kydes Pharmaceuticals

Kydes Pharmaceuticals, LLC is a start-up pharmaceutical company with a vision to design scientifically sound and cost-effective pharmaceutical products based on the knowledge and technologies

Century Pharmaceuticals

Century Pharmaceuticals is a generic drug manufacturer based in India.

P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.